Vigilant Capital Management, LLC Amgen Inc Transaction History

Vigilant Capital Management, LLC

$1.34 Billion
Q2 2023

A detailed history of Vigilant Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Vigilant Capital Management, LLC holds 4,129 shares of AMGN stock, worth $1.3 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

4,129

Previous 3,229 27.87%

Holding current value

$1.3 Million

Previous $781,000 17.41%

% of portfolio

0.07%

Previous 0.06%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	BUY	$214.27 - $253.37 $192,843 - $228,033	900 Added 27.87%	4,129 $917,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $1,145 - $1,455	-5 Reduced 0.15%	3,229 $848,000
Q1 2022 Apr 07, 2022	SELL	$219.27 - $242.57 $93,189 - $103,092	-425 Reduced 11.62%	3,234 $782,000
Q4 2021 Jan 06, 2022	BUY	$198.88 - $227.6 $145,977 - $167,058	734 Added 25.09%	3,659 $823,000
Q3 2021 Oct 08, 2021	SELL	$212.27 - $248.7 $13,797 - $16,165	-65 Reduced 2.17%	2,925 $622,000
Q2 2021 Jul 09, 2021	SELL	$233.58 - $259.14 $93,432 - $103,656	-400 Reduced 11.8%	2,990 $729,000
Q1 2021 Apr 16, 2021	BUY	$221.91 - $258.6 $25,519 - $29,739	115 Added 3.51%	3,390 $843,000
Q4 2020 Jan 14, 2021	BUY	$216.38 - $257.67 $3,245 - $3,865	15 Added 0.46%	3,275 $753,000
Q3 2020 Oct 15, 2020	BUY	$234.65 - $260.95 $58,662 - $65,237	250 Added 8.31%	3,260 $829,000
Q2 2020 Jul 10, 2020	SELL	$197.81 - $242.74 $49,452 - $60,685	-250 Reduced 7.67%	3,010 $710,000
Q1 2020 Apr 17, 2020	SELL	$182.24 - $241.7 $29,158 - $38,672	-160 Reduced 4.68%	3,260 $661,000
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $41,436 - $53,260	219 Added 6.84%	3,420 $824,000
Q3 2019 Oct 16, 2019	BUY	$174.11 - $208.62 $174 - $208	1 Added 0.03%	3,201 $619,000
Q2 2019 Jul 18, 2019	SELL	$166.7 - $195.41 $41,675 - $48,852	-250 Reduced 7.25%	3,200 $590,000
Q1 2019 Apr 09, 2019	BUY	$180.87 - $203.88 $14,650 - $16,514	81 Added 2.4%	3,450 $655,000
Q4 2018 Jan 15, 2019	SELL	$178.4 - $208.25 $229,779 - $268,226	-1,288 Reduced 27.66%	3,369 $656,000
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $368,912 - $415,899	1,991 Added 74.68%	4,657 $965,000
Q2 2018 Jul 11, 2018	SELL	$166.05 - $186.51 $2,324 - $2,611	-14 Reduced 0.52%	2,666 $492,000
Q1 2018 Apr 04, 2018	BUY	$169.43 - $198.0 $45,576 - $53,262	269 Added 11.16%	2,680 $457,000
Q4 2017 Jan 31, 2018	BUY	$168.79 - $188.59 $195,965 - $218,952	1,161 Added 92.88%	2,411 $419,000
Q3 2017 Oct 13, 2017	BUY	$167.29 - $191.0 $209,112 - $238,750	1,250	1,250 $233,000

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vigilant Capital Management, LLC with notifications on news.

Account

Vigilant Capital Management, LLC Amgen Inc Transaction History